Investigating the safety and effectiveness of conditioned medium injection of stem cells in male androgenetic alopecia

Phase 1

Recruiting

• Conditions: Hair Loss.; Nonscarring hair loss, unspecified; L65.9

• Registration Number: IRCT20200127046282N39
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Patients with male androgenetic alopecia grade 3-5
Age between 25 and 45 years

Exclusion Criteria

Presence of evidence of sepsis
immunosuppression and cancer
Use of oral drug treatment for androgenic hair loss (such as finasteride, dutasteride or any other anti-androgen drug) in 12 months the past
Use of local drug treatment of androgenic hair loss (such as minoxidil, prostaglandin analogues, retinoids or Corticosteroids) in the last 12 months
Discovering another cause for the patient's hair loss
Non-cooperation of the patient until the end of the study

Study & Design

• Study Type: interventional
• Study Design: Not specified